NSEShareholders meeting2d ago · 10 Aug 2026, 11:35 pm
Shareholders meeting
AstraZeneca Pharma India Limited · ASTRAZEN
✦ AI SummaryResults
AstraZeneca Pharma India Limited has held its 47th Annual General Meeting (AGM) on August 10, 2026, where it adopted financial statements, declared a dividend of Rs. 36 per equity share, and appointed new auditors and directors. The meeting was conducted through video conferencing, and remote e-voting was provided to members.
Analysis Scores
Earnings Impact8/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact9/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
AstraZeneca Pharma India Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 10, 2026
Attachments (1)
📄pdf
Download →
ASTRAZEN_10082026233540_Proceedings_of_AGM_2026.pdf
View document text
August 10, 2026
The Manager- Listing
BSE Limited
P J Towers, Dalal Street, Fort,
Mumbai - 400001
National Stock Exchange of India Limited
Exchange Plaza,
Bandra –Kurla Complex, Bandra (E),
Mumbai - 400051
Dear Sir/ Madam,
Sub: Summary of Proceedings of 47th Annual General Meeting
Ref: Scrip code –BSE: 506820, NSE: ASTRAZEN
Pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations
and Disclosure Requirements) Regulations, 2015, we wish to inform you that the 47th Annual
General Meeting ("AGM") of the Company was held on Monday, August 10, 2026 through
Video Conferencing ("VC")/Other Audio Visual Means ("OAVM"). As the requisite quorum
was not present at the scheduled time of 3:00 P.M., the AGM commenced at 3:18 P.M. and
concluded at 5:20 P.M. The following business items were transacted at the AGM:
1. Adoption of Financial Statements for the financial year ended March 31, 2026 and the
Reports of the Board of Directors and Auditors thereon.
2. Declaration of dividend of Rs. 36/- per equity share.
3. Appointment of Ms. Bhavana Agrawal (DIN: 10485441) who retires by rotation, and
being eligible, offers herself for re-appointment.
4. Appointment of M/s. BSR & Co. LLP, Chartered Accountants (Firm Registration No.
101248W/W- 00022) as the Statutory Auditors of the Company.
5. Re-appointment of Ms. Shilpa Divekar Nirula as an Independent Director for a second
term of five (5) years consecutive years commencing from December 29, 2026 to
December 28, 2031 (both days inclusive).
The Company had provided remote e-Voting facility to the members to exercise their votes
electronically from Thursday, August 6, 2026 at 9:00 a.m. (IST) and ended on Sunday, August
9, 2026 at 5:00 p.m. (IST) on the resolutions as set out at Item Nos. 1 to 5 of the Notice of the
AGM. Members who participated at the 47th AGM through VC/ OAVM facility and had not
cast their votes on the resolution(s) using remote e Voting, and who were otherwise eligible,
were provided facility to e-Vote on the NSDL portal during the AGM.
Kindly note that voting results will be announced upon the receipt of Scrutinizer’s Report and
will be submitted as per Regulation 44(3) of SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015.
Please take same on record.
Thanking you,
For AstraZeneca Pharma India Limited
Tanya Sanish
Company Secretary & Compliance Officer